BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38372299)

  • 21. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MLL-Rearranged Acute Lymphoblastic Leukemia.
    El Chaer F; Keng M; Ballen KK
    Curr Hematol Malig Rep; 2020 Apr; 15(2):83-89. PubMed ID: 32350732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral ovarian B-lineage lymphoblastic lymphoma with MLL gene rearrangement: a novel case in infancy.
    Larish AM; Dolan M; Casey T; Perkins JL
    J Pediatr Hematol Oncol; 2015 May; 37(4):e215-7. PubMed ID: 25493458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reciprocal ATP5L-KMT2A gene fusion in a paediatric B lymphoblastic leukaemia/lymphoma (B-ALL) patient.
    Gestrich CK; Sadri N; Sinno MG; Pateva I; Meyerson HJ
    Br J Haematol; 2020 Oct; 191(2):e61-e64. PubMed ID: 32729113
    [No Abstract]   [Full Text] [Related]  

  • 25. CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia and is distinctly low in KMT2A-rearranged cases.
    Collins K; Cardinali JL; Mnayer LO; DiGiuseppe JA
    Cytometry B Clin Cytom; 2021 Mar; 100(2):243-248. PubMed ID: 31894899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relapsed infant MLL-rearranged acute lymphoblastic leukemia with additional genetic alterations.
    Ishida H; Kanamitsu K; Washio K; Muraoka M; Sakakibara K; Matsubara T; Kanzaki H; Shimada A
    Pediatr Blood Cancer; 2016 Nov; 63(11):2059-60. PubMed ID: 27322816
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapy-induced Deletion in 11q23 Leading to Fusion of
    Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
    Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a t(11;19), KMT2A Rearranged B-ALL Cell Line for Preclinical Evaluation and Novel Therapeutics Development for Refractory Infant Leukemia.
    Sharma R; Incoronato A; Zhang C; Jayanthan A; Shah R; Narendran A
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e750-e756. PubMed ID: 37494611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the Role of Hematopoietic Cell Transplantation (HCT) for Pediatric Acute Lymphoblastic Leukemia (ALL) in the Age of Chimeric Antigen Receptor T-Cell (CART) Therapy?
    Taraseviciute A; Broglie L; Phelan R; Bhatt NS; Becktell K; Burke MJ
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):337-344. PubMed ID: 30973486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia.
    Wander P; Cheung LC; Pinhan̉«os SS; Jones L; Kerstjens M; Arentsen-Peters STCJM; Singh S; Chua GA; Castro PG; Schneider P; Dolman MEM; Koopmans B; Molenaar JJ; Pieters R; Zwaan CM; Kotecha RS; Stam RW
    Leukemia; 2020 Nov; 34(11):2898-2902. PubMed ID: 32488115
    [No Abstract]   [Full Text] [Related]  

  • 32. The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
    Stumpel DJ; Schneider P; Pieters R; Stam RW
    Eur J Cancer; 2015 Sep; 51(14):2008-21. PubMed ID: 26188848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.
    Breese EH; Krupski C; Nelson AS; Perentesis JP; Phillips CL
    J Pediatr Hematol Oncol; 2021 May; 43(4):152-154. PubMed ID: 32496443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haploidentical peripheral blood stem cell transplantation without irradiation or busulfan after reduced-intensity conditioning for KMT2A(MLL)-rearranged infant B-cell precursor acute lymphoblastic leukemia: Report of two cases.
    Yoshimi A; Kato K; Hosaka S; Suzuki R; Fukushima H; Nakao T; Kobayashi C; Fukushima T; Koike K; Sumazaki R; Tsuchida M
    Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28332262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)-rearranged infant acute lymphoblastic leukaemia.
    Emerenciano M; Barbosa Tda C; de Almeida Lopes B; Meyer C; Marschalek R; Pombo-de-Oliveira MS
    Br J Haematol; 2015 Jul; 170(2):268-71. PubMed ID: 25613690
    [No Abstract]   [Full Text] [Related]  

  • 36. Inv(11)(q21q23); KMT2A-MAML2, a Recurrent Genetic Abnormality in T-Cell Therapy-related Acute Lymphoblastic Leukemia.
    Mariani RA; Silva M; Caparelli E; Jennings LJ; Yap KL; Leuer KM; Weinstein J; Gong S
    J Pediatr Hematol Oncol; 2020 May; 42(4):e258-e261. PubMed ID: 31343482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel KMT2A-ACTN2 fusion in infant B-cell acute lymphoblastic leukemia.
    Yoshida M; Nakabayashi K; Ogata-Kawata H; Osumi T; Tsujimoto SI; Shirai R; Yoshida K; Okamura K; Matsumoto K; Kiyokawa N; Tomizawa D; Hata K; Kato M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27821. PubMed ID: 31115144
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantification of NG2-positivity for the precise prediction of KMT2A gene rearrangements in childhood acute leukemia.
    Zerkalenkova E; Mikhaylova E; Lebedeva S; Illarionova O; Baidun L; Kashpor S; Osipova E; Maschan M; Maschan A; Novichkova G; Olshanskaya Y; Popov A
    Genes Chromosomes Cancer; 2021 Feb; 60(2):88-99. PubMed ID: 33135273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk-adapted therapeutic stratification of infantile acute lymphocytic leukemia based on MLL-gene rearrangement].
    Tomizawa D
    Rinsho Ketsueki; 2008 Mar; 49(3):171-81. PubMed ID: 18421958
    [No Abstract]   [Full Text] [Related]  

  • 40. Trametinib inhibits
    Kerstjens M; Pinhancos SS; Castro PG; Schneider P; Wander P; Pieters R; Stam RW
    Haematologica; 2018 Apr; 103(4):e147-e150. PubMed ID: 29419436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.